查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371939

全球 HIV 诊断市场，到 2030 年的预测：按产品、测试类型、最终用户和地区进行的全球分析

HIV Diagnosis Market Forecasts to 2030 - Global Analysis By Product, Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球 HIV 诊断市场规模将达到 10.596 亿美元，预计到 2030 年将达到 17.579 亿美元，预测期内年复合成长率为 7.4%。

HIV诊断是指辨识个体体内是否存在人类免疫力缺乏病毒（HIV）的过程。这通常是透过各种实验室测试来完成的，这些测试可检测血液、唾液和其他体液中病毒的特异性标记，例如 HIV 抗体和病毒遗传物质。准确的诊断对于确定个人的爱滋病毒状况至关重要，对于开始治疗、控制疾病和预防其传播也至关重要。

根据世界卫生组织（WHO）统计，2016年全球约有3,600万人被诊断出感染爱滋病毒，其中210万人是新感染者。

爱滋病毒诊断的需求不断增长

人类免疫力缺乏病毒（HIV）会导致后天免疫力缺乏症候群，可以透过爱滋病毒诊断来检测，从而增加了对这些服务的需求。此外，由于可以透过检测血清、唾液和尿液来诊断 HIV，并有助于检测抗体、抗原和 RNA，因此 HIV 诊断流程的销售额预计将增加。此外，随着人们对爱滋病毒、检测保密性和适当咨询的了解越来越多，对爱滋病毒诊断的需求也在增加。因此，由于这些要素，爱滋病毒诊断市场预计将迅速扩大。

成本高

HIV 诊断测试可能很昂贵，具体取决于情况和测试类型，特别是如果它们先进且精确的话。此外，与检测相关的成本可能是一个障碍，特别是对于资源匮乏地区或无法获得足够医疗保健的人来说。其结果是，市场扩张将受到明显抑制。

政府系统和计划

世界各国政府正在加紧配合措施，透过实施优先考虑预防、检测和治疗的综合计画来对抗爱滋病毒/爱滋病流行。此外，这些计划旨在提高常规爱滋病毒检测的普及，特别是在高风险族群中，并让人们获得最先进的诊断工具。此外，各国政府也鼓励製药公司、非政府组织(NGO) 和医疗保健组织之间进行合作，以提高爱滋病毒诊断设备的可用性和成本，从而减轻全球爱滋病毒负担。透过共同努力实现这一目标，我们鼓励市场扩张。

缺乏知识和假阳性结果

许多人，特别是生活在高风险地区的人，不知道早期诊断的价值，对爱滋病毒检测的了解也有限。检测率低和诊断延迟可能是由于缺乏教育和意识，阻碍了适当的管理和预防措施。此外，假阳性会导致过度的担忧和压力，而假阴性会延迟诊断并增加病毒感染的风险。因此，这些要素正逐渐阻碍市场规模。

COVID-19 的影响

冠状病毒 (COVID-19)大流行导致的全球封锁正在影响各行业公司的财务健康状况。此外，由于政府封锁、旅行限制和其他 COVID-19 安全措施，全球供应链和製造业务也受到了影响。因此，爱滋病毒诊断检测的需求预计在流行期间会减少。

预计设备部分在预测期内将是最大的

由于可以利用专门的医疗工具和技术来检测和追踪爱滋病毒感染，因此设备部分估计占最大份额。此外，这些技术使医疗保健专业人员能够准确地识别患者样本中的爱滋病毒抗体和病毒遗传物质。这些设备的范例包括 PCR 机、ELISA 分析仪和快速检测仪等诊断工具。此外，这些尖端工具对于早期检测、疾病监测和研究至关重要，从而实现快速、准确的爱滋病毒检测。我们也帮助医疗保健专业人员、实验室和诊所提供有效的诊断解决方案，并促进继续配合措施遏制爱滋病毒的传播。因此，这些要素正在显着推动市场规模。

CD4 测试领域预计在预测期内年复合成长率最高

预计 CD4 测试领域在预测期内年复合成长率最高。 CD4 检测对于控制 HIV/爱滋病至关重要，因为它可以指示疾病的病程并检测患者免疫系统的健康状况。此外，这些测试可以帮助医疗专业人员决定治疗计划并评估抗逆转录病毒药物的有效性。此外，准确、快速的 CD4 检测对于指导患者护理和控制疾病至关重要。因此，透过在爱滋病毒诊断市场中发挥重要作用，我们将为改善爱滋病毒感染者的治疗结果和整体生活品质做出贡献。

比最大的地区

由于印度、中国和日本等国家宣传活动的加强和爱滋病毒诊断数量的增加，亚太地区在预测期内占据了最大的市场占有率。此外，社会经济和人口要素的变化正在增加这些国家的爱滋病毒诊断数量。此外，增加对医疗机构和意识计划的投资也支持亚太地区的市场扩张。

复合年复合成长率最高的地区

由于在促进早期检测、制定国家检测政策和增加爱滋病毒检测服务的可及性方面取得了重大进展，预计欧洲在预测期内的年复合成长率最高。此外，该地区的目标是减少与爱滋病毒相关的耻辱和歧视，从而鼓励人们接受检测。此外，政府、医疗机构和非政府组织之间的合作有助于提高检测率并加快诊断速度，从而显着促进欧洲地区的市场扩张。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球爱滋病毒诊断市场：副产品

  • 软体和服务
  • 装置
  • 消耗品
    • 测定及试剂盒/试剂
    • 其他消耗品

第6章全球 HIV 诊断市场：依测试类型

  • 抗体测试
    • HIV-1 筛检测试
      • 酵素连结免疫吸附试验
      • 首页访问干血斑
      • 快速测试
    • HIV-1抗体确认试验
      • 蛋白质印迹试验
      • 线性免疫分析
      • 间接萤光分析 (IFA)
      • 放射免疫沉淀测定
    • HIV-2 和 O 组诊断测试
  • 病毒量测试
  • 婴儿早期诊断测试
  • CD4测试
  • 病毒鑑定测试

第7章全球 HIV 诊断市场：依最终用户分类

  • 医院/诊所
  • 诊断实验室
  • 居家医疗环境
  • 其他最终用户

第8章全球爱滋病毒诊断市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Abbott Laboratories
  • Roche Diagnostics
  • Merck KGaA
  • Siemens Healthineers
  • Thermo-Fisher Scientific Inc.
  • Beckman Coulter, Inc.
  • Hologic Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories
  • Alere Inc.
  • OraSure Technologies, Inc.
  • Zyomyx Incorporation
  • Chembio Diagnostic Systems, Inc.
  • Janssen Pharmaceutica NV
  • Bristol-Myers Squibb
Product Code: SMRC23996

According to Stratistics MRC, the Global HIV Diagnosis Market is accounted for $1059.6 million in 2023 and is expected to reach $1757.9 million by 2030 growing at a CAGR of 7.4% during the forecast period. HIV diagnosis refers to the process of identifying the presence of the human immunodeficiency virus (HIV) in an individual's body. It is typically accomplished through various laboratory tests that detect specific markers of the virus, such as HIV antibodies or viral genetic material in blood, saliva, or other bodily fluids. The accurate diagnosis is essential for determining an individual's HIV status, which is crucial for initiating treatment, managing the disease, and preventing its spread.

According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections.

Market Dynamics:

Driver:

Rising demand for HIV diagnosis

Since the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome, may be detected by HIV diagnostics, by which there is an increasing need for these services. Moreover, testing serum, saliva, or urine samples allows for the diagnosis of HIV and as these methods assist in detecting antibodies, antigens, and RNA, it is projected that sales of HIV diagnostic processes will rise. Additionally, as people become more knowledgeable about HIV, the confidentiality of the test, and appropriate counselling, the demand for HIV diagnostics is also rising. Hence, the HIV diagnostics market is anticipated to expand quickly as a result of these factors.

Restraint:

High expenses

HIV diagnostic tests can be expensive, particularly for more sophisticated and precise testing procedures, depending on the context and type of test. Additionally, costs associated with testing can be an obstacle, especially in environments with few resources or for people without access to adequate healthcare. Consequently, this considerably disrupts the market's expansion.

Opportunity:

Government schemes and programs

Worldwide, governments are stepping up their efforts to tackle the HIV/AIDS pandemic by putting in place comprehensive plans that prioritize prevention, testing, and treatment. Additionally, these programs seek to increase the prevalence of routine HIV testing, particularly among high-risk populations, and to open up access to cutting-edge diagnostic tools. Furthermore, governments also encourage collaborations among pharmaceutical firms, non-governmental organizations (NGOs), and healthcare organizations to increase the accessibility and cost of HIV diagnostic equipment, which in turn drives market expansion as they cooperate to mitigate the burden of HIV worldwide

Threat:

Lack of knowledge and false-positive results

A lot of people, especially those who live in high-risk areas, can be unaware of the value of early diagnosis and have limited knowledge about HIV testing. Low testing rates and delayed diagnoses might be caused by a lack of education and awareness actions, hindering adequate management and prevention measures. Furthermore, false-positive results can result in too much worry and stress, while false-negative results can delay diagnosis and increase the risk of virus transmission. Thus, these factors gradually hamper the size of the market.

COVID-19 Impact

The global lockdown caused by the corona virus (COVID-19) pandemic has had an effect on the financial health of companies in all industries. Additionally, global supply chains and manufacturing operations have been affected as a result of government-enforced lockdowns, mobility restrictions, and other COVID-19 safety measures. Therefore, during the epidemic, the need for HIV diagnostic tests is anticipated to decline.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is estimated to hold the largest share, due to utilizing specialized medical tools and technology, HIV infection is detected and tracked. Additionally, these technologies enable medical personnel to precisely identify HIV antibodies or viral genetic material in patient samples. Examples of these devices include diagnostic tools including PCR machines, ELISA analyzers, and quick test readers. Moreover, these cutting-edge tools are essential for early detection, disease monitoring, and research, enabling quick and accurate HIV testing. They also assist healthcare professionals, labs, and clinics in delivering efficient diagnostic solutions, which helps to further the continuing efforts to restrict the spread of HIV. Therefore, these factors significantly drive the market's size.

The CD4 Tests segment is expected to have the highest CAGR during the forecast period

The CD4 Tests segment is anticipated to have highest CAGR during the forecast period. CD4 tests are essential for controlling HIV/AIDS since they show the disease's course and measure the patient's immune system's health. Additionally, these tests assist medical professionals in deciding on a course of treatment and assessing the efficacy of antiretroviral medication. Moreover, for directing patient care and managing diseases, accurate and prompt CD4 testing is essential. Thus, it contributes to better treatment outcomes and overall quality of life for people with HIV by playing a vital role in the market for HIV diagnosis.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness-raising campaigns in nations like India, China, and Japan have increased the number of HIV diagnoses. Moreover, because of shifting socioeconomic and demographic factors, there are more HIV diagnoses in these nations. Additionally, rising healthcare institution and awareness program investments are driving market expansion in the Asia Pacific region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant progress in boosting early detection, creating national testing policies, and increasing access to HIV testing services. Additionally, the area aims to reduce the stigma and discrimination related to HIV, which encourages people to be tested. Furthermore, governments, healthcare institutions, and NGOs working together have increased testing rates and accelerated diagnosis which thus significantly propels the market expansion in Europe region.

Key players in the market:

Some of the key players in the HIV Diagnosis Market include: Abbott Laboratories, Roche Diagnostics, Merck KGaA, Siemens Healthineers, Thermo-Fisher Scientific Inc., Beckman Coulter, Inc., Hologic Inc., Becton, Dickinson & Company , Bio-Rad Laboratories, Alere Inc., OraSure Technologies, Inc., Zyomyx Incorporation, Chembio Diagnostic Systems, Inc., Janssen Pharmaceutica NV and Bristol -Myers Squibb.

Key Developments:

In August 2023, Abbott Laboratories has collaborated with Redcliffe Labs to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This development aims to revolutionise healthcare, offering solutions to enhance patient care and convenience.

In Jan 2022, Bristol-Myers Squibb and Century Therapeutics enter into a strategic collaboration to develop iPSC-derived Allogeneic Cell Therapies. The collaboration with Century Therapeutics is an important part of their investment strategy in next-generation cell therapies for hematologic and solid tumors.

Products Covered:

  • Software & Services
  • Instruments
  • Consumables

Test Types Covered:

  • Antibody Tests
  • Viral Load Tests
  • Tests for Early Infant Diagnosis
  • CD4 Tests
  • Tests for Viral Identification

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global HIV Diagnosis Market, By Product

  • 5.1 Introduction
  • 5.2 Software & Services
  • 5.3 Instruments
  • 5.4 Consumables
    • 5.4.1 Assays and Kits & Reagents
    • 5.4.2 Other Consumables

6 Global HIV Diagnosis Market, By Test Type

  • 6.1 Introduction
  • 6.2 Antibody Tests
    • 6.2.1 HIV-1 Screening Tests
      • 6.2.1.1 Elisa
      • 6.2.1.2 Home Access Dried Blood Spots
      • 6.2.1.3 Rapid Tests
    • 6.2.2 HIV-1 Antibody Confirmatory Tests
      • 6.2.2.1 Western Blot Tests
      • 6.2.2.2 Line Immunoassays
      • 6.2.2.3 Indirect Immunofluorescence Assays (IFA)
      • 6.2.2.4 Radio-Immunoprecipitation Assays
    • 6.2.3 HIV-2 & Group O Diagnostic Tests
  • 6.3 Viral Load Tests
  • 6.4 Tests for Early Infant Diagnosis
  • 6.5 CD4 Tests
  • 6.6 Tests for Viral Identification

7 Global HIV Diagnosis Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals & Clinics
  • 7.3 Diagnostic Laboratories
  • 7.4 Home Settings
  • 7.5 Other End Users

8 Global HIV Diagnosis Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Roche Diagnostics
  • 10.3 Merck KGaA
  • 10.4 Siemens Healthineers
  • 10.5 Thermo-Fisher Scientific Inc.
  • 10.6 Beckman Coulter, Inc.
  • 10.7 Hologic Inc.
  • 10.8 Becton, Dickinson & Company
  • 10.9 Bio-Rad Laboratories
  • 10.10 Alere Inc.
  • 10.11 OraSure Technologies, Inc.
  • 10.12 Zyomyx Incorporation
  • 10.13 Chembio Diagnostic Systems, Inc.
  • 10.14 Janssen Pharmaceutica NV
  • 10.15 Bristol -Myers Squibb

List of Tables

  • Table 1 Global HIV Diagnosis Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 4 Global HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 6 Global HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 7 Global HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 8 Global HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 9 Global HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 10 Global HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 11 Global HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 12 Global HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 13 Global HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 14 Global HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 15 Global HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 16 Global HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 17 Global HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 19 Global HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 20 Global HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 21 Global HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 22 North America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 24 North America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 25 North America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 26 North America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 27 North America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 28 North America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 29 North America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 30 North America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 31 North America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 32 North America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 33 North America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 34 North America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 35 North America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 36 North America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 37 North America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 38 North America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 North America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 40 North America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 41 North America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 42 North America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 43 Europe HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Europe HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 45 Europe HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 46 Europe HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 47 Europe HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 48 Europe HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 49 Europe HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 50 Europe HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 51 Europe HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 52 Europe HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 53 Europe HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 54 Europe HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 55 Europe HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 56 Europe HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 57 Europe HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 58 Europe HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 59 Europe HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 60 Europe HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 61 Europe HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 62 Europe HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 63 Europe HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 64 Asia Pacific HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 65 Asia Pacific HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 66 Asia Pacific HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 67 Asia Pacific HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 68 Asia Pacific HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 69 Asia Pacific HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 70 Asia Pacific HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 71 Asia Pacific HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 72 Asia Pacific HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 73 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 74 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 75 Asia Pacific HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 76 Asia Pacific HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 77 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 78 Asia Pacific HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 79 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 80 Asia Pacific HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 Asia Pacific HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 82 Asia Pacific HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 83 Asia Pacific HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 84 Asia Pacific HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 85 South America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 86 South America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 87 South America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 88 South America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 89 South America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 90 South America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 91 South America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 92 South America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 93 South America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 94 South America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 95 South America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 96 South America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 97 South America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 98 South America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 99 South America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 100 South America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 101 South America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 102 South America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 103 South America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 104 South America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 105 South America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 106 Middle East & Africa HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 107 Middle East & Africa HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 108 Middle East & Africa HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 109 Middle East & Africa HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 110 Middle East & Africa HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 111 Middle East & Africa HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 112 Middle East & Africa HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 113 Middle East & Africa HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 114 Middle East & Africa HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 115 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 116 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 117 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 118 Middle East & Africa HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 119 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 120 Middle East & Africa HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 121 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 122 Middle East & Africa HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 123 Middle East & Africa HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 124 Middle East & Africa HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 125 Middle East & Africa HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 126 Middle East & Africa HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)